Second-look laparotomy in managing epithelial ovarian carcinoma

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Chemotherapy Research

Background:

• Epithelial ovarian carcinoma (EOC) treatment involves initial surgery and chemotherapy.
• Assessing treatment response and residual disease is critical for patient outcomes.
• Second-look operations (SLO) are used to evaluate the effectiveness of primary treatment.

Purpose of the Study:

• To evaluate the role of second-look operations (SLO) in epithelial ovarian carcinoma.
• To correlate SLO findings with initial surgery, chemotherapy, and patient survival.
• To assess the impact of secondary debulking procedures on patient prognosis.

Main Methods:

• Retrospective analysis of 51 patients with epithelial ovarian carcinoma.
• Patients underwent initial laparotomy, cytoreductive surgery, and cisplatin-based chemotherapy.
• Second-look operations (SLO) were performed to assess residual disease and treatment response.

Main Results:

• SLO findings were often predictable based on initial surgery and clinical response.
• Negative SLO after incomplete initial surgery indicated a 34% complete response rate.
• Patients with negative SLO had a 93% 3-year survival rate, demonstrating prognostic value.

Conclusions:

• Second-look operation is valuable for assessing peritoneal cavity status and chemotherapy efficacy in EOC.
• Negative SLO findings significantly correlate with improved patient survival.
• Secondary debulking of residual tumor warrants further investigation to improve survival rates.